[Pharmacokinetics of tolbutamide and glycodiazine in liver and kidney diseases].
D004987:Ethers / Q000097:blood / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000378:metabolism*; D007674:Kidney Diseases / Q000378:metabolism*; D008107:Liver Diseases / Q000378:metabolism*; D011743:Pyrimidines / Q000097:blood / Q000378:metabolism*; D013449:Sulfonamides / Q000097:blood / Q000378:metabolism*; D014044:Tolbutamide / Q000097:blood / Q000378:metabolism*
D004987:Ethers; D007004:Hypoglycemic Agents; D011743:Pyrimidines; D013449:Sulfonamides; D014044:Tolbutamide
Uber die Pharmakokinetik von Tolbutamid und Glykodiazin bei Leber- und Nierenschäden.